down arrow

Sunil Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE671C01016
  • NSEID:
  • BSEID: 537253
INR
74.85
1.35 (1.84%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 26

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

74.8575.00

52 Week

58.55104.00
Valuation
Technical
Day's Volume

CASH

26 (-95.74%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.10%

Held by 0 DIIs

Promoter

73.53%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.60%

  • Poor long term growth as Net Sales has grown by an annual rate of 2.72% and Operating profit at 19.43% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.76 times
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 77 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.87

stock-summary
Return on Equity

-1.91%

stock-summary
Price to Book

1.12

Revenue and Profits (1 Year):
Net Sales:
20 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.01%
0%
-18.01%
1 Year
18.81%
0%
18.81%
2 Years
15.67%
0%
15.67%
3 Years
13.24%
0%
13.24%
4 Years
203.04%
0%
203.04%
5 Years
389.22%
0%
389.22%

Sunil Healthcare for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.72%
EBIT Growth (5y)
19.43%
EBIT to Interest (avg)
0.95
Debt to EBITDA (avg)
5.23
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
21.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
3.04%
ROE (avg)
4.46%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
27
Price to Book Value
1.12
EV to EBIT
35.36
EV to EBITDA
13.54
EV to Capital Employed
1.06
EV to Sales
1.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.56%
ROE (Latest)
-1.91%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Anil Kumar Khaitan (57.95%)

Highest Public shareholder

Shailesh Kumar (5.75%)

Individual Investors Holdings

17.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.99% vs -5.77% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.82% vs 20.29% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20.46",
          "val2": "20.26",
          "chgp": "0.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.70",
          "val2": "2.32",
          "chgp": "16.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.89",
          "val2": "1.50",
          "chgp": "26.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.54",
          "val2": "-0.55",
          "chgp": "1.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.20%",
          "val2": "11.45%",
          "chgp": "1.75%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -9.65% vs -27.85% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 28.74% vs -127.58% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41.75",
          "val2": "46.21",
          "chgp": "-9.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.52",
          "val2": "2.04",
          "chgp": "121.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.01",
          "val2": "2.58",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.24",
          "val2": "-1.74",
          "chgp": "28.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.83%",
          "val2": "4.41%",
          "chgp": "6.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -9.68% vs -22.81% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.25% vs -131.14% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.21",
          "val2": "68.88",
          "chgp": "-9.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.22",
          "val2": "1.41",
          "chgp": "412.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.90",
          "val2": "4.02",
          "chgp": "21.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.78",
          "val2": "-1.94",
          "chgp": "8.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.61%",
          "val2": "2.05%",
          "chgp": "9.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -18.37% vs -7.28% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -126.80% vs 4.05% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "90.19",
          "val2": "110.49",
          "chgp": "-18.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.09",
          "val2": "16.16",
          "chgp": "-74.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.78",
          "val2": "4.17",
          "chgp": "38.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.79",
          "val2": "6.68",
          "chgp": "-126.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.53%",
          "val2": "14.63%",
          "chgp": "-10.10%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
20.46
20.26
0.99%
Operating Profit (PBDIT) excl Other Income
2.70
2.32
16.38%
Interest
1.89
1.50
26.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.54
-0.55
1.82%
Operating Profit Margin (Excl OI)
13.20%
11.45%
1.75%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 0.99% vs -5.77% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 1.82% vs 20.29% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
41.75
46.21
-9.65%
Operating Profit (PBDIT) excl Other Income
4.52
2.04
121.57%
Interest
3.01
2.58
16.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.24
-1.74
28.74%
Operating Profit Margin (Excl OI)
10.83%
4.41%
6.42%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -9.65% vs -27.85% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 28.74% vs -127.58% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
62.21
68.88
-9.68%
Operating Profit (PBDIT) excl Other Income
7.22
1.41
412.06%
Interest
4.90
4.02
21.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.78
-1.94
8.25%
Operating Profit Margin (Excl OI)
11.61%
2.05%
9.56%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -9.68% vs -22.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 8.25% vs -131.14% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
90.19
110.49
-18.37%
Operating Profit (PBDIT) excl Other Income
4.09
16.16
-74.69%
Interest
5.78
4.17
38.61%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.79
6.68
-126.80%
Operating Profit Margin (Excl OI)
4.53%
14.63%
-10.10%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -18.37% vs -7.28% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -126.80% vs 4.05% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Sunil Healthcare Ltd stock-summary
stock-summary
Sunil Healthcare Ltd
Micro Cap
Pharmaceuticals & Drugs
Sunil Healthcare Limited (Formerly known Sunil Synchem Ltd) was incorporated in 1973. The Company introduced plant at Alwar; Rajasthan for manufacture of Empty Hard Gelatin Capsule Shells and HPMC Capsules Shell. With continuous efforts and improvements in policy & adherence to top-notch quality monitoring measures, the Company became the second-largest manufacturer of Empty Hard Gelatin Capsules (EHGC) in India.
Company Coordinates stock-summary
Company Details
38E/252-A 1st Flr, Vijay Tower Shahpurjat New Delhi New Delhi : 110049
stock-summary
Tel: 91-11-49435555
stock-summary
http://www.sunilhealthcare.com
stock-summary
info@sunilhealthcare.com
Registrar Details
Alankit Assignments Ltd , Alankit House , 2 E/21, Jhandewala Extension, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."